Nutrition Health Chat: Tuesday, Dec. 8th, 5-6 PM Eastern. Learn how vitamins, minerals, and phytonutrients affect your health. Free live Q&A. Join us!
Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum.  ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
 | 

Antiviral cross-restance chart

by zellyf, May 15, 2008 05:35PM
Cross-Resistance of Current HBV Drugs

Resistance to HBV antiviral drugs can limit which treatment options are
available in the future. If HBV is resistant to one drug, it will sometimes
be resistant to similar drugs in the same group. This is called
"cross-resistance" and it means that some anti-HBV drugs will not work even
though they have not used been used before.

If resistant to: Lamivudine
Then, will be resistant to these drugs:
Yes = Lamivudine
No = Adefovir
No = Tenofovir
Yes = Telbivudine
*Reduced = Entecavir


If resistant to: Adefovir
Then, will be resistant to these drugs:
No = Lamivudine
Yes = Adefovir
**Reduced = Tenofovir
No = Telbivudine
No = Entecavir


If resistant to: Telbivudine
Then, will be resistant to these drugs:
Yes = Lamivudine
No = Adefovir
No  = Tenofovir
Yes = Telbivudine
**Reduced = Entecavir


If resistant to: Entecavir
Then, will be resistant to these drugs:
Yes = Lamivudine
No = Adefovir
No = Tenofovir
Yes = Telbivudine
Yes = Entecavir


* Reduced ­ initially the drug-resistant virus is sensitive to entecavir,
but often the virus eventually becomes resistant to the drug.

** Reduced ­ in the lab, the virus is sensitive to the drug; clinically,
it¹s resistant (probably because of higher drug levels in humans).

Sources:
Locarnini S. Molecular virology and the development of resistant mutants:
implications for therapy. Semin Liver Dis. 2005;25 Suppl 1:9-19.
Fournier C. and Zoulim, F. Antiviral therapy of chronic hepatitis B:
prevention of drug resistance. Clin Liver Dis (2007) 869-892.
Member Comments (4)

by cajim, May 15, 2008 07:21PM
Very clear and helpful.  Thanks.

by zellyf, May 15, 2008 07:21PM
Restance? Really? No.  RESISTANCE. Doh.

by NashPred, May 15, 2008 07:41PM
To: zelly
LOL...I think we've all wished for an edit feature on these boards a time or two.
Lucky for all of us that we're not being graded on mis-spelled words.

by stevenNYer, May 17, 2008 10:46PM
To: Zelly
Awesome post.
Post Comment
To
Comment
Post Comment
Recent Activity
Occult HCV infection: an unexpected... updated
1 hr ago by mikesimon
rooboo NOT WORTHY
I don't get it, again
Dec 07 by joe710
healthyhappy joined this community
Welcome them!
Dec 06
jibon_can joined this community
Welcome them!
Dec 06
Kantaka joined this community
Welcome them!
Dec 05
lost100 joined this community
Welcome them!
Dec 04
Blood test yesterday
Dec 04 by joe710
RSS Expert Activity
7 Ways to Reduce Stress During the ...
23 hrs ago by Steven Y Park, MD
What You Can Learn From Tiger Woods...
Dec 04 by Steven Y Park, MD
When the Mexican Drug Trade Hits th...
Dec 03 by Arnold L Goldman, D.V.M.
Community Members